MIRASOL PATHOGEN REDUCTION TECHNOLOGY MODULATES PLATELET OXIDATIVE STRESS

被引：0
|
作者：
Johnson, L. N. [1 ]
Marks, D. C. [1 ]
机构：
[1] Australian Red Cross Blood Serv, Alexandria, Australia
来源：
VOX SANGUINIS | 2013年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [1] Treatment of Platelet Concentrates with the Mirasol Pathogen Inactivation System Modulates Platelet Oxidative Stress and NF-κB Activation
    Johnson, Lacey
    Marks, Denese
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2015, 42 (03) : 169 - 175
  • [2] Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology
    Li, JZ
    Lockerbie, O
    de Korte, D
    Rice, J
    McLean, R
    Goodrich, RP
    [J]. TRANSFUSION, 2005, 45 (06) : 920 - 926
  • [3] Inactivation of HCV with the Mirasol® Pathogen Reduction Technology
    Harb, M.
    Helle, F.
    Duverlie, G.
    [J]. TRANSFUSION, 2010, 50 : 211A - 211A
  • [4] The Mirasol® Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution
    Reikvam, Hakon
    Marschner, Susanne
    Apelseth, Torunn Oveland
    Goodrich, Ray
    Hervig, Tor
    [J]. BLOOD TRANSFUSION, 2010, 8 (03) : 186 - 192
  • [5] A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen reduction technology
    Salunkhe, Vishal
    De Cuyper, Iris M.
    Papadopoulos, Petros
    van der Meer, Pieter F.
    Daal, Brunette B.
    Villa-Fajardo, Maria
    de Korte, Dirk
    van den Berg, Timo K.
    Gutierrez, Laura
    [J]. PLATELETS, 2019, 30 (03) : 368 - 379
  • [6] A COMPREHENSIVE PROTEOMICS STUDY ON PLATELET CONCENTRATES: PLATELET PROTEOME, STORAGE TIME AND MIRASOL PATHOGEN REDUCTION TECHNOLOGY
    Salunkhe, V.
    van Alphen, F.
    De Cuyper, I. M.
    Nota, B.
    van der Zwaan, C.
    van der Meer, P. F.
    Daal, B. B.
    De Korte, D.
    Meijer, A. B.
    van den Berg, T. K.
    Gutierrez, L.
    [J]. HAEMATOLOGICA, 2017, 102 : 141 - 141
  • [7] Effects of a new pathogen-reduction technology (Mirasol PRT) on platelet function.
    Diaz-Ricart, M
    Perez-Pujol, S
    Tonda, R
    Lozano, M
    Fuste, B
    Lopez-Vilchez, I
    Galan, AM
    Li, JZ
    Goodrich, R
    Escolar, G
    [J]. BLOOD, 2004, 104 (11) : 988A - 988A
  • [8] Analysis of platelets treated with Mirasol® Pathogen Reduction Technology and stored in platelet additive solution (PAS)
    Marschner, S.
    Cardigan, R.
    Cookson, P.
    de Korte, Dirk
    Dumont, Larry J.
    Einarson, M.
    Herschel, L.
    Janetzko, K.
    Vassallo, R.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 148A - 148A
  • [9] Analysis of plasma ratio and cell quality of platelet hyperconcentrates treated with mirasol® pathogen reduction technology
    Marschner, S.
    Buytaert-Hoefen, K. A.
    Hovenga, N. A.
    Dumont, D. F.
    Herschel, L. H.
    Roger, J.
    Dumont, L. J.
    Aubuchon, J. P.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2007, 47 (03) : 81A - 81A
  • [10] Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates
    Perez-Pujol, S
    Tonda, R
    Lozano, M
    Fuste, B
    Lopez-Vilchez, I
    Galan, AM
    Li, J
    Goodrich, R
    Escolar, G
    [J]. TRANSFUSION, 2005, 45 (06) : 911 - 919
12345